| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:29902490; PMID:33359579 |
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:39986363 |
| GO:0000084 | Mitotic s phase | Increases phenotype | PMID:30248417; PMID:36065135; PMID:39986363 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Increases phenotype | PMID:36065135; PMID:39986363 |
| GO:0000122 | Negative regulation of transcription by rna polymerase ii | Increases phenotype | PMID:25851902 |
| GO:0000165 | Mapk cascade | Increases phenotype | PMID:20002897; PMID:20363256 |
| GO:0000278 | Mitotic cell cycle | Increases phenotype | PMID:25559859 |
| GO:0001503 | Ossification | Affects phenotype | PMID:25062436; PMID:28298639; PMID:28758259; PMID:30878453; PMID:31472278; PMID:34020675; PMID:38081572 |
| GO:0001544 | Initiation of primordial ovarian follicle growth | Decreases phenotype | PMID:34537908 |
| GO:0001552 | Ovarian follicle atresia | Increases phenotype | PMID:34537908 |
| GO:0001649 | Osteoblast differentiation | Affects phenotype | PMID:23111315; PMID:28921615; PMID:28975700; PMID:30312686; PMID:30738844; PMID:34562440; PMID:39986363 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:39067743 |
| GO:0001890 | Placenta development | Affects phenotype | PMID:25912570 |
| GO:0002027 | Regulation of heart rate | Increases phenotype | PMID:10780258; PMID:15769980; PMID:7947501 |
| GO:0002076 | Osteoblast development | Increases phenotype | PMID:27028516 |
| GO:0002232 | Leukocyte chemotaxis involved in inflammatory response | Increases phenotype | PMID:22446600; PMID:27452194 |
| GO:0002296 | T-helper 1 cell lineage commitment | Decreases phenotype | PMID:36350155 |
| GO:0002297 | T-helper 2 cell lineage commitment | Increases phenotype | PMID:36350155 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:31751647; PMID:36350155 |
| GO:0002437 | Inflammatory response to antigenic stimulus | Increases phenotype | PMID:25739523 |
| GO:0002441 | Histamine secretion involved in inflammatory response | Increases phenotype | PMID:36350155 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:25739523; PMID:25878373; PMID:26363199; PMID:31860763; PMID:33140555; PMID:27565714; PMID:28300665; PMID:28694203; PMID:28694203; PMID:29458014; PMID:30849337; PMID:32812458; PMID:34401976; PMID:34455893; PMID:34998855; PMID:35335934; PMID:35481609; PMID:37004399; PMID:38729284; PMID:39067743 |
| GO:0002526 | Acute inflammatory response | Increases phenotype | PMID:22099998 |
| GO:0002539 | Prostaglandin production involved in inflammatory response | Decreases phenotype | PMID:25314295 |
| GO:0002674 | Negative regulation of acute inflammatory response | Increases phenotype | PMID:22099998 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:25891457; PMID:31751647 |
| GO:0002725 | Negative regulation of t cell cytokine production | Increases phenotype | PMID:19997594 |
| GO:0002922 | Positive regulation of humoral immune response | Increases phenotype | PMID:23892921 |
| GO:0002930 | Trabecular meshwork development | Increases phenotype | PMID:28214551 |
| GO:0003331 | Positive regulation of extracellular matrix constituent secretion | Increases phenotype | PMID:26492236 |
| GO:0003415 | Chondrocyte hypertrophy | Increases phenotype | PMID:27608943 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:23108452; PMID:23111315; PMID:25062436; PMID:25448682; PMID:26089034; PMID:27387537; PMID:28921615; PMID:28975700; PMID:32473317; PMID:34020675; PMID:34562440; PMID:35866224; PMID:39986363; PMID:8745575 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:23108452; PMID:34998855; PMID:35866224 |
| GO:0004111 | Creatine kinase activity | Increases phenotype | PMID:26089034 |
| GO:0004364 | Glutathione transferase activity | Increases phenotype | PMID:19788401; PMID:28483492 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:23108452; PMID:26089034; PMID:28300665; PMID:34998855 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:21801858; PMID:30849337; PMID:32687258; PMID:35866224; PMID:38511873 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:26363199; PMID:31860763; PMID:37177863; PMID:38511873; PMID:38901789; PMID:30849337; PMID:30924981; PMID:32687258; PMID:32812458; PMID:35866224; PMID:37177863; PMID:37696682 |
| GO:0004935 | Adrenergic receptor activity | Increases phenotype | PMID:26419632 |
| GO:0005980 | Glycogen catabolic process | Affects phenotype | PMID:1566830; PMID:61140; PMID:6142694 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:37337224 |
| GO:0006029 | Proteoglycan metabolic process | Affects phenotype | PMID:35148621 |
| GO:0006071 | Glycerol metabolic process | Affects phenotype | PMID:33476690 |
| GO:0006094 | Gluconeogenesis | Increases phenotype | PMID:22676303; PMID:3827816; PMID:3876337 |
| GO:0006096 | Glycolytic process | Decreases phenotype | PMID:26670611 |
| GO:0006260 | Dna replication | Decreases phenotype | PMID:39986363 |
| GO:0006264 | Mitochondrial dna replication | Increases phenotype | PMID:32417366 |
| GO:0006308 | Dna catabolic process | Increases phenotype | PMID:2429833; PMID:35866224 |
| GO:0006309 | Apoptotic dna fragmentation | Increases phenotype | PMID:10331302; PMID:11090465; PMID:11399061; PMID:11399061; PMID:9371682; PMID:11421811; PMID:12400870; PMID:15133238; PMID:15964614; PMID:9466323; PMID:1641906; PMID:17953376; PMID:19070971; PMID:19339209; PMID:21244764; PMID:7673702; PMID:7728769; PMID:7777588; PMID:7831194; PMID:7831194; PMID:8376790; PMID:8132215; PMID:8376790; PMID:9326359; PMID:9371682; PMID:9466323 |
| GO:0006355 | Regulation of dna-templated transcription | Affects phenotype | PMID:35483669 |
| GO:0006412 | Translation | Decreases phenotype | PMID:23493372; PMID:33567340 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:33359579 |
| GO:0006536 | Glutamate metabolic process | Affects phenotype | PMID:32445661; PMID:32494933; PMID:34189720 |
| GO:0006600 | Creatine metabolic process | Affects phenotype | PMID:34998855 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:31778773; PMID:34273429; PMID:34273429; PMID:34500009; PMID:34500009 |
| GO:0006629 | Lipid metabolic process | Increases phenotype | PMID:18586010; PMID:31596606 |
| GO:0006635 | Fatty acid beta-oxidation | Increases phenotype | PMID:26670611 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:30446312; PMID:34302803; PMID:35589016; PMID:36708982; PMID:36764644 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:31860763 |
| GO:0006695 | Cholesterol biosynthetic process | Affects phenotype | PMID:32234517 |
| GO:0006699 | Bile acid biosynthetic process | Affects phenotype | PMID:29222744 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:21801858; PMID:26089034; PMID:28363435; PMID:35866224; PMID:37177863; PMID:37696682 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:25448682; PMID:26360969; PMID:28088388 |
| GO:0006805 | Xenobiotic metabolic process | Increases phenotype | PMID:11091129; PMID:12695342; PMID:19903449 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:22185406; PMID:23373965; PMID:26271896 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:34189720; PMID:37337224 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:19855186; PMID:33359579; PMID:36708982; PMID:38286393 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:10200551; PMID:10331302; PMID:10453071; PMID:10453071; PMID:14996839; PMID:16445836; PMID:8554984; PMID:10572627; PMID:10919278; PMID:11012613; PMID:11012613; PMID:11776405; PMID:11040338; PMID:11044214; PMID:11090465; PMID:11114198; PMID:11311531; PMID:11311531; PMID:29111458; PMID:11319611; PMID:11331073; PMID:11397893; PMID:11399061; PMID:9070360; PMID:9147362; PMID:11399663; PMID:11421811; PMID:11677114; PMID:11692113; PMID:11751287; PMID:11751517; PMID:11756569; PMID:12094262; PMID:12234484; PMID:12238564; PMID:12400870; PMID:12513834; PMID:14996839; PMID:9016789; PMID:12589357; PMID:12730077; PMID:12746047; PMID:14632786; PMID:14633444; PMID:14982598; PMID:14996839; PMID:15133238; PMID:15330010; PMID:15343345; PMID:15353912; PMID:15388240; PMID:15491851; PMID:15574755; PMID:15574755; PMID:16505121; PMID:15576458; PMID:15705788; PMID:15799306; PMID:15829407; PMID:15964614; PMID:15987750; PMID:15990687; PMID:16151648; PMID:16164824; PMID:16330256; PMID:1641906; PMID:16445836; PMID:16462032; PMID:16462032; PMID:18476001; PMID:16505121; PMID:16616082; PMID:16944584; PMID:17070682; PMID:17180084; PMID:17690025; PMID:17953376; PMID:18437985; PMID:18515658; PMID:18611438; PMID:18830898; PMID:21597759; PMID:19005922; PMID:19080409; PMID:19339209; PMID:19891978; PMID:20067466; PMID:20578217; PMID:20578217; PMID:30878453; PMID:21244764; PMID:21277400; PMID:21277400; PMID:28940008; PMID:21442075; PMID:21569845; PMID:25612170; PMID:27608943; PMID:28940008; PMID:29928335; PMID:30526067; PMID:30628712; PMID:30878453; PMID:34189720; PMID:39986363; PMID:7517174; PMID:7524498; PMID:7540953; PMID:7549842; PMID:7579413; PMID:7673702; PMID:7728769; PMID:7777588; PMID:7831194; PMID:7831194; PMID:8376790; PMID:7945400; PMID:8048048; PMID:7969078; PMID:8048048; PMID:8132215; PMID:8338788; PMID:8376790; PMID:8630077; PMID:8660802; PMID:8825066; PMID:9016789; PMID:9029185; PMID:9042522; PMID:9147362; PMID:9326359; PMID:9371682; PMID:9374718; PMID:9408059; PMID:9528991; PMID:9531328; PMID:9790906 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:11137978; PMID:25841707 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:26089034; PMID:29458014; PMID:30924981; PMID:31669322 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:21986892; PMID:26739637 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:12414515; PMID:16678324; PMID:19969022; PMID:19997867 |
| GO:0007005 | Mitochondrion organization | Affects phenotype | PMID:34323617; PMID:35866224 |
| GO:0007033 | Vacuole organization | Increases phenotype | PMID:29222744 |
| GO:0007040 | Lysosome organization | Increases phenotype | PMID:39393751 |
| GO:0007049 | Cell cycle | Decreases phenotype | PMID:10335920; PMID:10383846; PMID:11751517; PMID:12734332; PMID:15266821; PMID:1641906; PMID:16510457; PMID:16707792; PMID:1806033; PMID:18395440 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:30526067; PMID:36790081 |
| GO:0007406 | Negative regulation of neuroblast proliferation | Increases phenotype | PMID:29524569 |
| GO:0007613 | Memory | Decreases phenotype | PMID:34189720 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:32234517 |
| GO:0008209 | Androgen metabolic process | Increases phenotype | PMID:19903449 |
| GO:0008217 | Regulation of blood pressure | Increases phenotype | PMID:10584476; PMID:10780258; PMID:15769980; PMID:16158007; PMID:16740865; PMID:9858113; PMID:10780258; PMID:15050533; PMID:15050533; PMID:18753797; PMID:15106802; PMID:1656149; PMID:16603690; PMID:18753797; PMID:19644504; PMID:24218149; PMID:24587916; PMID:2706798; PMID:282066; PMID:3015796; PMID:6276583; PMID:2719105; PMID:3142437; PMID:9865512 |
| GO:0008219 | Cell death | Affects phenotype | PMID:12953835; PMID:12967722; PMID:16403471; PMID:16644695; PMID:17591945; PMID:1806033; PMID:19855186; PMID:19969022; PMID:22471522; PMID:23872705; PMID:2429833; PMID:24519941; PMID:27387537; PMID:29222744; PMID:6284950 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:10335920; PMID:10383846; PMID:10690878; PMID:11040338; PMID:11162775; PMID:11751517; PMID:11792629; PMID:11831116; PMID:12539583; PMID:18097517; PMID:14632786; PMID:15266821; PMID:16045733; PMID:16239108; PMID:16707792; PMID:17077316; PMID:1806033; PMID:18395440; PMID:19158320; PMID:1917160; PMID:20363256; PMID:20922465; PMID:21351055; PMID:23872705; PMID:24239970; PMID:24239970; PMID:6832067; PMID:24576443; PMID:24646949; PMID:24930440; PMID:2547564; PMID:2547564; PMID:8206753; PMID:26468166; PMID:27387537; PMID:29111458; PMID:29458014; PMID:29624291; PMID:30359671; PMID:30878453; PMID:33359579; PMID:34323617; PMID:36065135; PMID:3606722; PMID:39909212; PMID:39986363; PMID:6689138; PMID:6832067; PMID:7264675; PMID:7348582; PMID:7549842; PMID:7621058; PMID:8157359; PMID:9024675; PMID:9184091; PMID:9442036; PMID:9580644 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:26468166; PMID:26821882; PMID:27816694; PMID:28031460; PMID:29288687 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:23137833; PMID:32619553; PMID:32791177; PMID:34742744 |
| GO:0008361 | Regulation of cell size | Increases phenotype | PMID:19158320; PMID:6319489 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:23493372; PMID:24576443; PMID:27003841; PMID:27475717; PMID:27475717; PMID:30248417; PMID:28625492; PMID:30248417; PMID:30408883; PMID:3041967; PMID:31154084; PMID:35589016 |
| GO:0009448 | Gamma-aminobutyric acid metabolic process | Affects phenotype | PMID:32445661; PMID:35595036 |
| GO:0009604 | Detection of symbiotic bacterium | Affects phenotype | PMID:38729284 |
| GO:0010455 | Positive regulation of cell fate commitment | Increases phenotype | PMID:30133442 |
| GO:0010460 | Positive regulation of heart rate | Increases phenotype | PMID:30940551 |
| GO:0010694 | Positive regulation of alkaline phosphatase activity | Increases phenotype | PMID:22940495; PMID:31935364 |
| GO:0010719 | Negative regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:32619553 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:22940495; PMID:24587916 |
| GO:0010765 | Positive regulation of sodium ion transport | Increases phenotype | PMID:1328298 |
| GO:0010867 | Positive regulation of triglyceride biosynthetic process | Increases phenotype | PMID:26164185; PMID:31053639 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:15273253; PMID:17290005; PMID:17290005; PMID:30133442; PMID:27273607; PMID:28031460; PMID:28285642; PMID:27605626; PMID:28031460; PMID:28285642; PMID:29782964; PMID:30133442; PMID:30382123; PMID:30611848; PMID:34560244 |
| GO:0010890 | Positive regulation of sequestering of triglyceride | Increases phenotype | PMID:25761413; PMID:26200599; PMID:26820058; PMID:30721698; PMID:29288687; PMID:30721698 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:26164185 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:38286393 |
| GO:0010940 | Positive regulation of necrotic cell death | Increases phenotype | PMID:22940495 |
| GO:0010942 | Positive regulation of cell death | Affects phenotype | PMID:19760634; PMID:23063726; PMID:25447644; PMID:25786529; PMID:25851902; PMID:8014883 |
| GO:0014732 | Skeletal muscle atrophy | Increases phenotype | PMID:33567340 |
| GO:0014889 | Muscle atrophy | Increases phenotype | PMID:31706954 |
| GO:0014902 | Myotube differentiation | Affects phenotype | PMID:36822333 |
| GO:0014904 | Myotube cell development | Decreases phenotype | PMID:34464682 |
| GO:0015707 | Nitrite transport | Increases phenotype | PMID:37777167 |
| GO:0015908 | Fatty acid transport | Affects phenotype | PMID:34323617; PMID:35589016 |
| GO:0015980 | Energy derivation by oxidation of organic compounds | Affects phenotype | PMID:26670611 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:10067847; PMID:12906939; PMID:16835395; PMID:18328801; PMID:26363199; PMID:27085773; PMID:28292967; PMID:30526067; PMID:30849337; PMID:30924981; PMID:31860763; PMID:32687258; PMID:34302803; PMID:34627953; PMID:36031164 |
| GO:0016043 | Cellular component organization | Affects phenotype | PMID:35483669 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:25612170; PMID:28940008 |
| GO:0016160 | Amylase activity | Increases phenotype | PMID:37177863 |
| GO:0016477 | Cell migration | Affects phenotype | PMID:24722316; PMID:25497111; PMID:31471547; PMID:31669322; PMID:33157413 |
| GO:0019216 | Regulation of lipid metabolic process | Affects phenotype | PMID:26164185 |
| GO:0019226 | Transmission of nerve impulse | Decreases phenotype | PMID:21282223 |
| GO:0019395 | Fatty acid oxidation | Decreases phenotype | PMID:38676573 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:23493372; PMID:24418828; PMID:24576443; PMID:25900201; PMID:27163856; PMID:28292967; PMID:29094436; PMID:30055130; PMID:30665118 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:37177863 |
| GO:0019722 | Calcium-mediated signaling | Decreases phenotype | PMID:8648096 |
| GO:0019915 | Lipid storage | Increases phenotype | PMID:28291828; PMID:30382123 |
| GO:0021781 | Glial cell fate commitment | Decreases phenotype | PMID:29524569 |
| GO:0022008 | Neurogenesis | Decreases phenotype | PMID:33619658 |
| GO:0030154 | Cell differentiation | Increases phenotype | PMID:10614771; PMID:11416043; PMID:14632786; PMID:14984747; PMID:14984747; PMID:15748605; PMID:16330256; PMID:16997883; PMID:17690025; PMID:1917160; PMID:20717928; PMID:21350315; PMID:6882797; PMID:7517174; PMID:7654470; PMID:7909661 |
| GO:0030194 | Positive regulation of blood coagulation | Increases phenotype | PMID:23696885 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:34998855 |
| GO:0030282 | Bone mineralization | Increases phenotype | PMID:25062436; PMID:27028516; PMID:27387537; PMID:28975700; PMID:30738844; PMID:31709877; PMID:34562440; PMID:35148621; PMID:38971901; PMID:39986363 |
| GO:0030316 | Osteoclast differentiation | Affects phenotype | PMID:30878453; PMID:39393751 |
| GO:0030317 | Flagellated sperm motility | Decreases phenotype | PMID:36790081 |
| GO:0030324 | Lung development | Affects phenotype | PMID:26283537 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:26468166 |
| GO:0030336 | Negative regulation of cell migration | Increases phenotype | PMID:32619553 |
| GO:0030501 | Positive regulation of bone mineralization | Increases phenotype | PMID:26468166; PMID:34575692 |
| GO:0030512 | Negative regulation of transforming growth factor beta receptor signaling pathway | Increases phenotype | PMID:29329878 |
| GO:0030887 | Positive regulation of myeloid dendritic cell activation | Increases phenotype | PMID:28463086 |
| GO:0031323 | Regulation of cellular metabolic process | Affects phenotype | PMID:26820058 |
| GO:0031941 | Filamentous actin | Increases phenotype | PMID:39393751 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:34189720 |
| GO:0032088 | Negative regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:23872422 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:35866224 |
| GO:0032148 | Activation of protein kinase b activity | Affects phenotype | PMID:28285642; PMID:28363435; PMID:30696844; PMID:32404561; PMID:35616142 |
| GO:0032310 | Prostaglandin secretion | Increases phenotype | PMID:37777167 |
| GO:0032332 | Positive regulation of chondrocyte differentiation | Increases phenotype | PMID:26526931 |
| GO:0032689 | Negative regulation of type ii interferon production | Increases phenotype | PMID:19997594 |
| GO:0032700 | Negative regulation of interleukin-17 production | Increases phenotype | PMID:19997594 |
| GO:0032725 | Positive regulation of granulocyte macrophage colony-stimulating factor production | Affects phenotype | PMID:23981542 |
| GO:0032922 | Circadian regulation of gene expression | Increases phenotype | PMID:29229235 |
| GO:0032963 | Collagen metabolic process | Increases phenotype | PMID:35335934 |
| GO:0032964 | Collagen biosynthetic process | Decreases phenotype | PMID:23493372; PMID:27028516 |
| GO:0032967 | Positive regulation of collagen biosynthetic process | Increases phenotype | PMID:31935364 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:26944108 |
| GO:0033327 | Leydig cell differentiation | Decreases phenotype | PMID:29902490; PMID:30526067 |
| GO:0034145 | Positive regulation of toll-like receptor 4 signaling pathway | Increases phenotype | PMID:27568862 |
| GO:0034199 | Activation of protein kinase a activity | Affects phenotype | PMID:29288687 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:22940495; PMID:26089034; PMID:28363435; PMID:32812458; PMID:34455893; PMID:35866224; PMID:37177863; PMID:37177863; PMID:38511873; PMID:38901789; PMID:37696682; PMID:38729284 |
| GO:0035377 | Transepithelial water transport | Decreases phenotype | PMID:31076804 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:33619658 |
| GO:0035774 | Positive regulation of insulin secretion involved in cellular response to glucose stimulus | Affects phenotype | PMID:25851902 |
| GO:0035784 | Nickel cation homeostasis | Decreases phenotype | PMID:27452194 |
| GO:0035810 | Positive regulation of urine volume | Increases phenotype | PMID:10334502; PMID:10334502; PMID:2719105; PMID:2719105 |
| GO:0035812 | Renal sodium excretion | Affects phenotype | PMID:10334502; PMID:2995143; PMID:3015796; PMID:7554322 |
| GO:0035930 | Corticosteroid hormone secretion | Affects phenotype | PMID:32445661 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:2818624; PMID:8014883; PMID:8386241 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:30628712 |
| GO:0040029 | Epigenetic regulation of gene expression | Decreases phenotype | PMID:35246761 |
| GO:0042102 | Positive regulation of t cell proliferation | Increases phenotype | PMID:28463086 |
| GO:0042116 | Macrophage activation | Decreases phenotype | PMID:2579101 |
| GO:0042127 | Regulation of cell population proliferation | Affects phenotype | PMID:2615355 |
| GO:0042178 | Xenobiotic catabolic process | Increases phenotype | PMID:9817083 |
| GO:0042221 | Response to chemical | Increases phenotype | PMID:35595036 |
| GO:0042307 | Positive regulation of protein import into nucleus | Increases phenotype | PMID:32619553 |
| GO:0042310 | Vasoconstriction | Affects phenotype | PMID:10484530; PMID:10598616; PMID:15802370; PMID:16603690; PMID:17562850; PMID:3631295; PMID:4058751 |
| GO:0042311 | Vasodilation | Increases phenotype | PMID:10484530; PMID:15769980 |
| GO:0042391 | Regulation of membrane potential | Affects phenotype | PMID:8179849 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:39909212 |
| GO:0042421 | Norepinephrine biosynthetic process | Decreases phenotype | PMID:21453761; PMID:29935188 |
| GO:0042445 | Hormone metabolic process | Affects phenotype | PMID:37177863 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:28940008; PMID:37177863 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:27653037; PMID:32791177 |
| GO:0042692 | Muscle cell differentiation | Decreases phenotype | PMID:22936724 |
| GO:0042908 | Xenobiotic transport | Affects phenotype | PMID:34998855 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:11426834; PMID:19760634; PMID:19997594; PMID:22010212; PMID:22940495; PMID:23063726; PMID:25447644; PMID:34742744; PMID:38336255 |
| GO:0043114 | Regulation of vascular permeability | Affects phenotype | PMID:29458014 |
| GO:0043124 | Negative regulation of i-kappab kinase/nf-kappab signaling | Increases phenotype | PMID:32619553 |
| GO:0043299 | Leukocyte degranulation | Decreases phenotype | PMID:7730645 |
| GO:0043966 | Histone h3 acetylation | Increases phenotype | PMID:33567340 |
| GO:0043967 | Histone h4 acetylation | Increases phenotype | PMID:33567340 |
| GO:0043970 | Histone h3-k9 acetylation | Affects phenotype | PMID:30359671; PMID:33619658; PMID:35246761 |
| GO:0043974 | Histone h3-k27 acetylation | Decreases phenotype | PMID:30359671; PMID:35246761 |
| GO:0044028 | Dna hypomethylation | Increases phenotype | PMID:29094436 |
| GO:0044154 | Histone h3-k14 acetylation | Decreases phenotype | PMID:35246761 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:17452641; PMID:29928335; PMID:31076804; PMID:32812458; PMID:33091441; PMID:35866224; PMID:37956312; PMID:39244184; PMID:39986363 |
| GO:0044242 | Cellular lipid catabolic process | Increases phenotype | PMID:29288687 |
| GO:0044255 | Cellular lipid metabolic process | Affects phenotype | PMID:34323617 |
| GO:0044307 | Dendritic branch | Affects phenotype | PMID:33619658 |
| GO:0045023 | G0 to g1 transition | Decreases phenotype | PMID:32023857; PMID:36065135 |
| GO:0045123 | Cellular extravasation | Increases phenotype | PMID:36031164 |
| GO:0045333 | Cellular respiration | Affects phenotype | PMID:31596606; PMID:32417366; PMID:34323617 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:27568862; PMID:28906110; PMID:32738331; PMID:34218561 |
| GO:0045444 | Fat cell differentiation | Affects phenotype | PMID:12496288; PMID:12496288; PMID:18586010; PMID:25338179; PMID:27384973; PMID:30959087; PMID:31078726; PMID:31154084; PMID:32017950; PMID:32220626; PMID:34302803; PMID:34323617; PMID:36152787; PMID:12496288; PMID:32017950; PMID:18591783; PMID:19064586; PMID:22732655; PMID:23503329; PMID:25559859; PMID:27475717; PMID:27507602; PMID:30248417; PMID:30409764; PMID:31199990; PMID:31470850; PMID:33945810; PMID:34968464; PMID:39842701; PMID:24418828; PMID:24576443; PMID:24646949; PMID:24646949; PMID:33026256; PMID:33203037; PMID:33689779; PMID:35504408; PMID:24911977; PMID:34800597; PMID:25062436; PMID:2523799; PMID:26996129; PMID:27085773; PMID:30446312; PMID:25338179; PMID:26117538; PMID:26504594; PMID:26972250; PMID:27085773; PMID:27507602; PMID:28291828; PMID:28298639; PMID:28437481; PMID:28528971; PMID:28528971; PMID:30408883; PMID:28625492; PMID:28628672; PMID:28758259; PMID:28849599; PMID:32473317; PMID:32522588; PMID:28921615; PMID:29094436; PMID:29704545; PMID:30055130; PMID:30248417; PMID:30408883; PMID:30446312; PMID:30665118; PMID:30665118; PMID:30920877; PMID:36708982; PMID:30738844; PMID:30920877; PMID:31154084; PMID:31596606; PMID:32017950; PMID:32407875; PMID:32473317; PMID:33395283; PMID:33476690; PMID:33836827; PMID:33865937; PMID:35736896; PMID:33945810; PMID:34323617; PMID:34800597; PMID:34864131; PMID:36065135; PMID:36706894; PMID:36708982; PMID:36764644; PMID:37142754; PMID:38048832; PMID:38971901 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:10777552; PMID:17290005; PMID:25617244; PMID:15273253; PMID:17290005; PMID:23917077; PMID:26820058; PMID:30031040; PMID:30721698; PMID:25617244; PMID:25851902; PMID:26408789; PMID:27273607; PMID:28031460; PMID:28285642; PMID:30577593; PMID:30903904; PMID:26200599; PMID:26408789; PMID:26492236; PMID:26824325; PMID:26944108; PMID:26944108; PMID:32171850; PMID:27145005; PMID:27605626; PMID:27714895; PMID:28031460; PMID:28163246; PMID:28242765; PMID:28595985; PMID:29410257; PMID:30611848; PMID:31319077; PMID:28285642; PMID:28527915; PMID:28595985; PMID:29782964; PMID:30031040; PMID:30382123; PMID:30577593; PMID:30721698; PMID:30903904; PMID:32044341; PMID:32171850; PMID:32553695; PMID:34560244 |
| GO:0045669 | Positive regulation of osteoblast differentiation | Affects phenotype | PMID:22940495; PMID:26424790; PMID:26492236; PMID:27714895; PMID:27932991; PMID:28189605; PMID:28363435; PMID:30382123; PMID:30639440; PMID:31935364 |
| GO:0045672 | Positive regulation of osteoclast differentiation | Increases phenotype | PMID:28363435 |
| GO:0045687 | Positive regulation of glial cell differentiation | Affects phenotype | PMID:27816694; PMID:29524569 |
| GO:0045722 | Positive regulation of gluconeogenesis | Increases phenotype | PMID:26616219 |
| GO:0045777 | Positive regulation of blood pressure | Increases phenotype | PMID:30940551 |
| GO:0045834 | Positive regulation of lipid metabolic process | Increases phenotype | PMID:32171850 |
| GO:0045907 | Positive regulation of vasoconstriction | Increases phenotype | PMID:27568862 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:30409764 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:30903904 |
| GO:0045944 | Positive regulation of transcription by rna polymerase ii | Increases phenotype | PMID:25851902 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:37337224 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:32812458; PMID:37177863; PMID:38901789; PMID:39067743 |
| GO:0046325 | Negative regulation of glucose import | Increases phenotype | PMID:32976960 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:37177863 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:6284950; PMID:9285037 |
| GO:0046620 | Regulation of organ growth | Decreases phenotype | PMID:19644504 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:32791177; PMID:34537908; PMID:35246761 |
| GO:0046651 | Lymphocyte proliferation | Increases phenotype | PMID:39067743 |
| GO:0046676 | Negative regulation of insulin secretion | Increases phenotype | PMID:32791177 |
| GO:0046685 | Response to arsenic-containing substance | Increases phenotype | PMID:33129825 |
| GO:0048266 | Behavioral response to pain | Increases phenotype | PMID:30261224 |
| GO:0048663 | Neuron fate commitment | Decreases phenotype | PMID:29524569 |
| GO:0050649 | Testosterone 6-beta-hydroxylase activity | Increases phenotype | PMID:25900201 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:32738331 |
| GO:0050872 | White fat cell differentiation | Increases phenotype | PMID:26972250; PMID:27605626; PMID:30133442; PMID:33412187 |
| GO:0050873 | Brown fat cell differentiation | Increases phenotype | PMID:25761413; PMID:26972250; PMID:32417366 |
| GO:0050901 | Leukocyte tethering or rolling | Increases phenotype | PMID:10807495; PMID:28559105 |
| GO:0050966 | Detection of mechanical stimulus involved in sensory perception of pain | Increases phenotype | PMID:33259823 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Affects phenotype | PMID:23063726; PMID:25080890; PMID:25851902 |
| GO:0051463 | Negative regulation of cortisol secretion | Increases phenotype | PMID:35246761 |
| GO:0051649 | Establishment of localization in cell | Affects phenotype | PMID:38729284 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:16944584; PMID:17070682; PMID:21244764; PMID:21569845; PMID:35866224; PMID:37337224 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:35866224 |
| GO:0055062 | Phosphate ion homeostasis | Affects phenotype | PMID:35738543; PMID:38971901 |
| GO:0055064 | Chloride ion homeostasis | Affects phenotype | PMID:35595036 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:35595036; PMID:38971901 |
| GO:0060013 | Righting reflex | Affects phenotype | PMID:30628712 |
| GO:0060055 | Angiogenesis involved in wound healing | Decreases phenotype | PMID:17295090 |
| GO:0060253 | Negative regulation of glial cell proliferation | Increases phenotype | PMID:29524569 |
| GO:0060326 | Cell chemotaxis | Affects phenotype | PMID:1659155; PMID:314231; PMID:3606722; PMID:7766432 |
| GO:0060348 | Bone development | Affects phenotype | PMID:35148621 |
| GO:0060480 | Lung goblet cell differentiation | Increases phenotype | PMID:34998855; PMID:35335934 |
| GO:0060591 | Chondroblast differentiation | Increases phenotype | PMID:26492236 |
| GO:0060612 | Adipose tissue development | Increases phenotype | PMID:10496339; PMID:11101056; PMID:20206132; PMID:31709877; PMID:33091441; PMID:9543393 |
| GO:0060644 | Mammary gland epithelial cell differentiation | Increases phenotype | PMID:28174119; PMID:31783125 |
| GO:0061351 | Neural precursor cell proliferation | Decreases phenotype | PMID:33619658 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:29902490; PMID:30526067; PMID:33983380 |
| GO:0061517 | Macrophage proliferation | Increases phenotype | PMID:37177863 |
| GO:0061756 | Leukocyte adhesion to vascular endothelial cell | Increases phenotype | PMID:32679256 |
| GO:0061951 | Establishment of protein localization to plasma membrane | Increases phenotype | PMID:30591588 |
| GO:0061975 | Articular cartilage development | Decreases phenotype | PMID:29329878 |
| GO:0070085 | Glycosylation | Increases phenotype | PMID:8392465 |
| GO:0070169 | Positive regulation of biomineral tissue development | Increases phenotype | PMID:22940495; PMID:26492236; PMID:28189605; PMID:30382123; PMID:31935364 |
| GO:0070212 | Protein poly-adp-ribosylation | Increases phenotype | PMID:22940495 |
| GO:0070257 | Positive regulation of mucus secretion | Increases phenotype | PMID:31751647 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:31053639 |
| GO:0070341 | Fat cell proliferation | Increases phenotype | PMID:38971901 |
| GO:0070346 | Positive regulation of fat cell proliferation | Increases phenotype | PMID:27605626; PMID:30382123; PMID:30903904 |
| GO:0070352 | Positive regulation of white fat cell proliferation | Increases phenotype | PMID:27605626 |
| GO:0070365 | Hepatocyte differentiation | Increases phenotype | PMID:20501703; PMID:28552552; PMID:23108452; PMID:26739637; PMID:36603777 |
| GO:0070368 | Positive regulation of hepatocyte differentiation | Increases phenotype | PMID:25084468; PMID:27427493 |
| GO:0070989 | Oxidative demethylation | Increases phenotype | PMID:22499231 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:34455893 |
| GO:0071441 | Negative regulation of histone h3-k14 acetylation | Increases phenotype | PMID:32791177 |
| GO:0071486 | Cellular response to high light intensity | Increases phenotype | PMID:24519941 |
| GO:0071577 | Zinc ion transmembrane transport | Increases phenotype | PMID:24311739 |
| GO:0071736 | Igg immunoglobulin complex, circulating | Increases phenotype | PMID:31669322 |
| GO:0071743 | Ige immunoglobulin complex, circulating | Increases phenotype | PMID:31669322 |
| GO:0071897 | Dna biosynthetic process | Decreases phenotype | PMID:33359579 |
| GO:0072540 | T-helper 17 cell lineage commitment | Increases phenotype | PMID:28463086 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:21801858; PMID:22471522; PMID:24239970; PMID:34998855; PMID:35866224; PMID:38286393 |
| GO:0072672 | Neutrophil extravasation | Affects phenotype | PMID:11557319; PMID:11820457; PMID:24188200; PMID:7542281 |
| GO:0072676 | Lymphocyte migration | Increases phenotype | PMID:35335934 |
| GO:0072677 | Eosinophil migration | Increases phenotype | PMID:31669322; PMID:35335934; PMID:37004399 |
| GO:0072682 | Eosinophil extravasation | Increases phenotype | PMID:24188200 |
| GO:0072683 | T cell extravasation | Increases phenotype | PMID:24188200 |
| GO:0090023 | Positive regulation of neutrophil chemotaxis | Increases phenotype | PMID:18670081 |
| GO:0090297 | Positive regulation of mitochondrial dna replication | Increases phenotype | PMID:29288687 |
| GO:0090336 | Positive regulation of brown fat cell differentiation | Increases phenotype | PMID:25761413; PMID:29288687 |
| GO:0097154 | Gabaergic neuron differentiation | Increases phenotype | PMID:32445661 |
| GO:0097280 | Histamine secretion mediated by immunoglobulin | Affects phenotype | PMID:2434566; PMID:6180017 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30526067 |
| GO:0098609 | Cell-cell adhesion | Increases phenotype | PMID:28559105 |
| GO:0098868 | Bone growth | Decreases phenotype | PMID:28363435; PMID:35148621 |
| GO:0110090 | Positive regulation of hippocampal neuron apoptotic process | Increases phenotype | PMID:31518422 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:19064586; PMID:26164185; PMID:28242765; PMID:28242765; PMID:28595985; PMID:30611848; PMID:28298639; PMID:28437481; PMID:28595985; PMID:28628672; PMID:28758259; PMID:28921615; PMID:29094436; PMID:30055130; PMID:30409764; PMID:30409764; PMID:31470850; PMID:33945810; PMID:30446312; PMID:30738844; PMID:30920877; PMID:30920877; PMID:36708982; PMID:31016361; PMID:31016361; PMID:34864131; PMID:31470850; PMID:32017950; PMID:32017950; PMID:32220626; PMID:36152787; PMID:32023857; PMID:32220626; PMID:32407875; PMID:32553695; PMID:33091441; PMID:33203037; PMID:33476690; PMID:33836827; PMID:33865937; PMID:33945810; PMID:34302803; PMID:34864131; PMID:35589016; PMID:36708982; PMID:36764644; PMID:37142754; PMID:38971901 |
| GO:0140059 | Dendrite arborization | Affects phenotype | PMID:33619658 |
| GO:0140115 | Export across plasma membrane | Decreases phenotype | PMID:28549670 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:37511356 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:38286393 |
| GO:1900035 | Negative regulation of cellular response to heat | Affects phenotype | PMID:14673132 |
| GO:1900171 | Positive regulation of glucocorticoid mediated signaling pathway | Increases phenotype | PMID:25851902 |
| GO:1900181 | Negative regulation of protein localization to nucleus | Increases phenotype | PMID:32619553 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:34537908; PMID:36350155 |
| GO:1900535 | Palmitic acid biosynthetic process | Increases phenotype | PMID:31053639 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:27568862; PMID:30721698; PMID:31935364; PMID:35616142 |
| GO:1901082 | Positive regulation of relaxation of smooth muscle | Affects phenotype | PMID:24380835 |
| GO:1901113 | Erythromycin metabolic process | Increases phenotype | PMID:16673044; PMID:16673044; PMID:16844145; PMID:16844145 |
| GO:1901331 | Positive regulation of odontoblast differentiation | Increases phenotype | PMID:35738543 |
| GO:1901666 | Positive regulation of nad+ adp-ribosyltransferase activity | Increases phenotype | PMID:22940495 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:28363435 |
| GO:1901675 | Negative regulation of histone h3-k27 acetylation | Increases phenotype | PMID:32791177 |
| GO:1901992 | Positive regulation of mitotic cell cycle phase transition | Increases phenotype | PMID:28285642 |
| GO:1902117 | Positive regulation of organelle assembly | Increases phenotype | PMID:29288687 |
| GO:1902512 | Positive regulation of apoptotic dna fragmentation | Increases phenotype | PMID:11137978 |
| GO:1902608 | Positive regulation of large conductance calcium-activated potassium channel activity | Increases phenotype | PMID:27605626 |
| GO:1903012 | Positive regulation of bone development | Increases phenotype | PMID:25932594 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:33359579; PMID:36065135; PMID:39986363 |
| GO:1903141 | Negative regulation of establishment of endothelial barrier | Increases phenotype | PMID:32404561 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:28181396; PMID:28940008 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:27568862 |
| GO:1903583 | Positive regulation of basophil degranulation | Increases phenotype | PMID:31751647 |
| GO:1904340 | Positive regulation of dopaminergic neuron differentiation | Increases phenotype | PMID:29524569 |
| GO:1904860 | Dna synthesis involved in mitotic dna replication | Increases phenotype | PMID:24646949 |
| GO:1905144 | Response to acetylcholine | Decreases phenotype | PMID:27568862 |
| GO:1905517 | Macrophage migration | Increases phenotype | PMID:31860763; PMID:35335934 |
| GO:1905962 | Glutamatergic neuron differentiation | Decreases phenotype | PMID:32445661 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:30924981; PMID:31860763; PMID:35335934; PMID:37004399 |
| GO:2000077 | Negative regulation of type b pancreatic cell development | Increases phenotype | PMID:32791177 |
| GO:2000324 | Positive regulation of glucocorticoid receptor signaling pathway | Increases phenotype | PMID:2298732 |
| GO:2000355 | Negative regulation of ovarian follicle development | Increases phenotype | PMID:34537908 |
| GO:2000376 | Positive regulation of oxygen metabolic process | Decreases phenotype | PMID:25851902 |
| GO:2000388 | Positive regulation of antral ovarian follicle growth | Increases phenotype | PMID:34537908 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:29960001; PMID:35616142 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:25739523 |
| GO:2000439 | Positive regulation of monocyte extravasation | Increases phenotype | PMID:29960001 |
| GO:2000490 | Negative regulation of hepatic stellate cell activation | Increases phenotype | PMID:26806094 |
| GO:2000491 | Positive regulation of hepatic stellate cell activation | Increases phenotype | PMID:26435214; PMID:26435214; PMID:26806094; PMID:26739621; PMID:26739621; PMID:29535048 |
| GO:2000553 | Positive regulation of t-helper 2 cell cytokine production | Increases phenotype | PMID:27884791 |
| GO:2000616 | Negative regulation of histone h3-k9 acetylation | Increases phenotype | PMID:32791177 |
| GO:2000738 | Positive regulation of stem cell differentiation | Affects phenotype | PMID:25786529; PMID:34575692 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Increases phenotype | PMID:25851902 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.